A detailed history of Gimbal Financial transactions in Eli Lilly & CO stock. As of the latest transaction made, Gimbal Financial holds 18,128 shares of LLY stock, worth $13.6 Million. This represents 10.49% of its overall portfolio holdings.

Number of Shares
18,128
Previous 18,201 0.4%
Holding current value
$13.6 Million
Previous $17 Billion 4.97%
% of portfolio
10.49%
Previous 12.51%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$772.14 - $960.02 $56,366 - $70,081
-73 Reduced 0.4%
18,128 $16.2 Billion
Q2 2024

Jul 12, 2024

SELL
$724.87 - $909.04 $300,096 - $376,342
-414 Reduced 2.22%
18,201 $17 Billion
Q1 2024

May 01, 2024

SELL
$592.2 - $792.28 $100,674 - $134,687
-170 Reduced 0.9%
18,615 $14.5 Billion
Q4 2023

Feb 01, 2024

BUY
$525.19 - $619.13 $9.87 Million - $11.6 Million
18,785 New
18,785 $11 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Gimbal Financial Portfolio

Follow Gimbal Financial and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gimbal Financial, based on Form 13F filings with the SEC.

News

Stay updated on Gimbal Financial with notifications on news.